Citation 117505

HALL,IH: WONG,OT: REYNOLDS,DJ: CHENG,JJ:. (1993). THE HYPOLIPIDEMIC EFFECTS OF 2-FUROIC ACID IN SPRAGUE-DAWLEY RATS.. 326(1)

Citation Details

Title	THE HYPOLIPIDEMIC EFFECTS OF 2-FUROIC ACID IN SPRAGUE-DAWLEY RATS.
Authors	HALL,IH: WONG,OT: REYNOLDS,DJ: CHENG,JJ:
Year	1993
Volume	326
Issue	1

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLYCERO-3-PHOSPHATE ACYL TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
2	GLYCERO-3-PHOSPHATE ACYL TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
3	CHOLESTEROL ESTER HYDROLASE ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROIC ACID,2:	ACTIVE
4	CHOLESTEROL ESTER HYDROLASE ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
5	HDL RECEPTOR ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
6	HDL RECEPTOR ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
7	LDL RECEPTOR ACTIVITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
8	LDL RECEPTOR ACTIVITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
9	LDL RECEPTOR ACTIVITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
10	LDL RECEPTOR ACTIVITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
11	LIPOPROTEIN LIPASE(LIVER)INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
12	PHOSPHATIDYLATE PHOSPHOHYDROLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
13	ACETYL CO-A SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
14	CITRATE LYASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
15	LIPOPROTEIN LIPASE(LIVER)INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
16	PHOSPHATIDYLATE PHOSPHOHYDROLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
17	ACETYL CO-A SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
18	CITRATE LYASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
19	CHOLESTEROL ACYLTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
20	HYPOCHOLESTEROLEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
21	HYPOTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	ACTIVE
22	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	FUROIC ACID,2:	.

Citation 117505

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1